Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer

NCT: NCT07492381 · NOT_YET_RECRUITING

NCT IDNCT07492381

StatusNOT_YET_RECRUITING

Brief Summary

The primary objective of this study is to evaluate the safety and effectiveness of PFA in patients with localized prostate cancer.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑